Observation on the therapeutic effect of glucocorticoid in severe pneumonia
Abstract
Objective: To observe the effect of glucocorticoid in severe pneumonia. Methods: 72 patients with severe pneumonia who were admitted to the ICU department of Ji'an city central people's hospital of Jiangxi province from January 2018 to January 2019 were treated by computer table method. Among them, 36 patients were included in the control group, and the rest 36 were included in the observation group. Results: The time cost of the observation group was less than that of the control group, P < 0.05. Conclusion: The combination of glucocorticoid in the treatment of severe pneumonia is more beneficial to the recovery of patients and reduces the time of suffering.
References
Sui Y. Effect of glucocorticoid on severe Mycoplasma pneumoniae pneumonia in children (in Chinese). China Practical Medical Journal 2015; 42(23): 128.
Zhang Z. Clinical observation of glucocorticoid therapy for severe Mycoplasma pneumoniae pneumonia (in Chinese). Continuing Medical Education 2015; 29(10): 159-160. doi: CNKI:SUN:JYJY.0.2015-10-123.
Hu Z, Liao J, Fu D. Clinical efficacy of glucocorticoid in treating severe Mycoplasma pneumoniae pneumonia in children (in Chinese). Modern Diagnosis and Treatment 2016; 27(21): 4061-4062. doi: 10.3969/j.issn.1001-8174.2016.21.039.
Copyright (c) 2019 Reports in Clinical Studies and Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors contributing to this journal agree to publish their articles under the Creative Commons Attribution-Noncommercial 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, that the work is not used for commercial purposes, and that in the event of reuse or distribution, the terms of this license are made clear. With this license, the authors hold the copyright without restrictions and are allowed to retain publishing rights without restrictions as long as this journal is the original publisher of the articles.
